Beta2-adrenergic receptor activation increases susceptibility to arrhythmogenesis in aging heart by impairing repolarization reserve via Giβγ–PLC signaling pathway Authors: Sihao Zou, Yi Wang, Jia Chen, Li Yan, Lijie Gao, Kexin Li, Xianying Wang, Congxin Li Published: 2026 ABSTRACT AbstractIn this study, age-related alterations in cardiac electrophysiology and the response to β2-adrenergic receptor (β2AR) activation were examined. Experiments were conducted in guinea pig hearts (in vivo, in vitro) and in human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) using a multielectrode array. Heart rate–corrected QT interval (QTc) and action potential duration (APD) were prolonged in aging hearts. The shortening of APD in response to increased pacing rates was markedly blunted in aged ventricular myocytes compared with young myocytes. β2AR agonist salbutamol (SAL) shortened QTc in a concentration-dependent manner in young hearts, whereas this response was absent in aging hearts, with susceptibility to ventricular tachyarrhythmias. In D-galactose–induced aging hiPSC-CMs, SAL-induced repolarization delay and cell arrhythmias, consistent with findings in aging hearts. In both aging hearts and hiPSC-CMs, the Gi inhibitor pertussis toxin, Gβγ inhibitor gallein, and the phospholipase C inhibitor U73122 reduced arrhythmogenesis. Furthermore, the slow delayed rectifier potassium channel (IKs) activator ML277 exerted a protective effect against aging-related arrhythmias. Overall, these findings indicate that β2AR activation increases susceptibility to arrhythmogenesis in aging hearts and D-galactose–induced aging hiPSC-CMs, whereas suppression of Giβγ–PLC signaling or activation of IKs may provide potential protection against aging-related repolarization delay and arrhythmias.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-54675-x.Keywords: β2-adrenoceptor, Aging, Arrhythmias, Human-induced pluripotent stem cell-derived cardiomyocytes, Slow delayed rectifier potassium channelsSubject terms: Cardiology, Cell biology, Medical research, Physiology Introduction Aging is an independent risk factor for the development of arrhythmia. During exercise and stress, sympathetic nerve activity in older individuals with cardiovascular disease can increase the risk of fatal arrhythmias and sudden cardiac death1. However, the molecular mechanism underlying the increased susceptibility to arrhythmogenesis in older individuals remains poorly understood. Acceleration of ventricular repolarization is a key adaptive response to sympathetic stimulation, allowing the heart to accommodate higher heart rates. Delayed rectifier K+ channels are central to determining the morphology and duration of the ventricular action potential (AP). The repolarizing delayed rectifier potassium current (IK) consists of a slowly activating component (IKs) and a rapidly activating component (IKr), both essential for repolarization of phases 2 and 3 of the AP in humans and other large mammals. Previous studies have shown that IKs, rather than IKr, is rapidly enhanced by β-adrenergic receptor (βAR) stimulation under elevated sympathetic tone, resulting in accelerated AP repolarization2. Consequently, IKs serves as a key reserve for ventricular repolarization3. Both β1AR and β2AR are present in the human ventricle. In the healthy adult heart, the β2AR-to-β1AR ratio is approximately 20:80, indicating the predominance of β1AR expression4. Activation of either β1AR or β2AR enhances IKs by coupling excitatory G proteins (Gs) to activate an adenylate cyclase (AC)–cyclic adenosine monophosphate (cAMP)–protein kinase A (PKA) signaling cascade5. Furthermore, PKA increases L-type calcium current and intracellular Ca2+, which, in turn, activates calmodulin (CaM). CaM binds to the C-terminal IQ motif of the IKs channel and exerts effects comparable to those of PKA. These effects are additive within a defined range of Ca2+ concentration6. Currently, there is no consensus regarding alterations in βAR and G protein signaling in aging hearts. However, evidence consistently suggests that, similar to heart failure, aging is associated with the deregulation of β1AR–Gs and the upregulation of β2AR–inhibitory G protein (Gi)7. Our previous study reported a marked increase in cardiac arrhythmias in aging guinea pigs and a concomitant reduction in cardiac IKs during stimulation with isoproterenol (a nonselective βAR agonist), mediated through the β2AR–Gi signaling pathway8. These findings suggest a potential role for βAR signaling bias in modulating IKs function and contributing to the increased susceptibility to arrhythmias in the aging heart. Therefore, this study was conducted to examine the impact of β2AR activation on age-related ventricular repolarization and to identify downstream effectors that mediate age-dependent susceptibility to arrhythmias, with potential implications for the development of antiarrhythmic strategies in older individuals. Methods Experimental animals Young male Dunkin–Hartley guinea pigs (1–3 months; 250–400 g) and aged male Dunkin–Hartley guinea pigs (≥ 24 months; 1000–1500 g) were purchased from Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). The animals were housed under controlled conditions, including room temperature of 25 °C, relative humidity of 50%–60%, and a 12-h light/dark cycle. All animals were fed standard laboratory food pellets and supplied ad libitum with filtered tap water. To minimize pain and distress, all guinea pigs were euthanized by cervical dislocation prior to tissue collection. All experimental procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. The study protocol was approved by the Animal Care and Use Committee of Hebei Medical University (Approval No. 1604087) and complied with the ARRIVE guidelines. Cardiac histology Heart tissue samples were fixed in 4% paraformaldehyde, dehydrated, embedded in paraffin wax, and serially sectioned at a thickness of 5–8 μm. Sections were mounted on glass slides and dried on a 45 °C hot plate for 30 min. Hematoxylin and eosin (H&E) staining was performed to evaluate myocardial histoarchitectural features, and Masson’s trichrome staining was used to assess the extent of myocardial fibrosis. Reactive oxygen species assay assessment Reactive oxygen species (ROS) levels in frozen sections of guinea pig hearts and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were assessed as previously described9. Briefly, the fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (Beyotime Biotechnology, China) was used, and representative images were captured using fluorescence microscopy. Staining for senescence-associated β-galactosidase Senescence-associated β-galactosidase staining of frozen sections of guinea pig hearts and hiPSC-CMs was performed according to the manufacturer’s protocol (Beyotime Biotechnology, China). Briefly, the samples were fixed in a fixative for 15 min and washed three times with phosphate-buffered saline. The samples were then treated with 1 mL of staining solution, sealed, and incubated overnight at 37 °C in the absence of CO2. The following day, the stained samples were examined under a light microscope. Electrocardiographic recordings The lead II surface electrocardiogram (ECG) waveforms were recorded using the Biopac MP150 system (Biopac Systems, USA). Guinea pigs were anesthetized with isoflurane (1%–2% in 100% oxygen) delivered via a nose cone. The depth of anesthesia was assessed by the absence of the pedal withdrawal reflex, and the isoflurane concentration was adjusted accordingly to maintain stable experimental conditions. Body temperature was maintained at 37 °C using a heating pad, and heart rate was continuously monitored to ensure hemodynamic stability. ECG recordings were initiated only after a 10-min stabilization period, during which heart rate variability was less than 5%. To assess arrhythmia susceptibility and to isolate direct cardiac effects from neurohumoral and metabolic influences, ex vivo hearts were used. Langendorff heart preparations were established using a previously described method8. Briefly, retrograde perfusion was performed at a flow rate of 4–6 mL/min and maintained at 37 °C ± 0.5 °C through the aorta using oxygenated Tyrode’s solution delivered by a peristaltic pump. The hearts were placed in a thermostatic chamber and allowed to equilibrate for at least 30 min to ensure stable ECG recordings before drug administration. Hearts exhibiting erratic rhythms on ECG recordings after the equilibration period were discarded. Hearts were initially perfused for 15 min with Tyrode’s solution containing pretreatment agents (e.g., pertussis toxin [PTX], gallein, U73122, and ML277). The perfusate was then switched to Tyrode’s solution containing both pretreatment agents and increasing concentrations of salbutamol (SAL) for 20 min. Subsequently, the hearts were washed out with Tyrode’s solution alone for 10 min. In vitro lead II–equivalent ECG waveforms were continuously recorded throughout the entire perfusion process using the Biopac MP150 system. The PR, QT, RR, and Tp–e intervals were measured directly and averaged over 10 consecutive beats in the presence and absence of the test compound, as previously described10. The heart rate–corrected QT (QTc) interval was calculated using the Bazett formula: QTc = QT/(RR0.5). The number of premature ventricular contractions (PVCs) was counted in tracings recorded 20 min after SAL administration. To minimize potential bias, all parameters were measured and analyzed by investigators who were blinded to the treatment conditions. Arrhythmia definitions and classification Ventricular arrhythmias, including PVCs, ventricular tachycardia (VT), and ventricular fibrillation (VF), were defined according to Lambeth Conventions II and international expert consensus statements11–13. PVCs were identified as premature ventricular beats characterized by a wide QRS complex without a preceding P wave. VT was defined as a sequence of at least three successive ventricular extrasystoles. VF was defined as a ventricular tachyarrhythmia with no identifiable ECG waveforms. Isolation of ventricular cardiomyocytes Single ventricular myocytes were enzymatically isolated from guinea pig hearts as previously described8. Briefly, guinea pigs were administered heparin (intraperitoneal, 1.0 U/kg) and anesthetized with sodium pentobarbital (35 mg/kg). The hearts were rapidly excised and mounted on a Langendorff apparatus. Retrograde aortic perfusion was performed using Ca2+-free Tyrode’s solution containing (in mM) NaCl 140, KCl 5.4, MgCl2 1, HEPES 10, and glucose 10 (pH adjusted to 7.4 with NaOH). After 3–5 min of perfusion, Tyrode’s solution was replaced with the same solution supplemented with type II collagenase (Worthington, 0.5 mg/mL). Once the ventricular tissue softened, the heart was removed from the apparatus, and the free wall of the left ventricular (LV) was dissected into small pieces. The tissue fragments were then immersed in a high-K+ solution containing (in mM) KOH 80, KCl 40, KH2PO4 25, MgSO4 3, glutamic acid 50, taurine 20, EGTA 0.5, HEPES 10, and glucose 10 (pH adjusted to 7.4 with KOH). Isolated single cardiomyocytes were harvested and subjected to patch-clamp recordings within 4–8 h. Patch-clamp recordings The standard whole-cell patch-clamp technique was used to record APs in LV myocytes using a MultiClamp 700B amplifier (Molecular Devices, USA). Electrical signals were sampled at 2.5–10 kHz, low-pass filtered at 1 kHz, and digitized using an analog-to-digital converter (Digidata 1322, Molecular Devices, USA). APs were evoked at rates of 0.5, 1, or 2 Hz using a suprathreshold current pulse of 2.0 nA with a duration of 5.5 ms delivered through patch electrodes in current-clamp mode. Action potential duration (APD) was measured at 90% repolarization (APD90). Recording electrodes (VitalSense Scientific Instruments Co., Ltd.) had tip resistances of 2–4 MΩ when filled with the pipette solution. The pipette solution contained (in mM) KCl 140, MgCl2 1, Mg-ATP 4, EGTA 5, and HEPES 10 (pH adjusted to 7.2 with KOH). The external solution contained (in mM) NaCl 138, KCl 4, CaCl2 2, MgCl2 1, NaH2PO4 0.33, glucose 10, and HEPES 10 (pH adjusted to 7.4 with NaOH). A perforated patch configuration was used, with patch pipettes backfilled with amphotericin B (600 ng/mL). All patch-clamp recordings were conducted at room temperature (23–24 °C). Data acquisition, protocol generation, and analysis were performed using pClamp software (Clampfit 10.4, Molecular Devices, USA). Measurement of myocardial inositol 1,4,5-trisphosphate levels LV tissue from isolated perfused hearts was collected after drug treatment and homogenized. Subsequent procedures were performed according to the manufacturer’s instructions for the inositol 1,4,5-trisphosphate (IP3) enzyme-linked immunosorbent assay (ELISA) kit (ESDChem, China). Absorbance was measured at 450 nm using a microplate reader, and IP3 concentrations were determined based on a standard curve. Cell viability Cell viability was assessed using a Cell Counting Kit-8 (CCK-8; Solarbio, China). The drug-containing medium was replaced with fresh medium supplemented with CCK-8 solution, followed by incubation at 37 °C for 2 h. Absorbance was then measured at 450 nm using a microplate reader. Culturing hiPSC-CMs and monitoring electrical activity using CardioExcyte 96 HiPSC-CMs purchased from Cellapy Biotechnology Co., Ltd. (catalog number: CA2201106; Beijing, China) were characterized by immunostaining using antibodies against cardiomyocyte-specific proteins, including cardiac troponin T and α-actinin. The cells were stored in liquid nitrogen prior to thawing and were cultured according to the manufacturer’s instructions. Briefly, hiPSC-CMs were thawed and seeded at a density of 4 × 10⁴ cells per well into Matrigel (Corning, USA)-precoated CardioExcyte 96 sensor plates (NSP96–0.6 mm). The cultures were maintained in a humidified incubator at 37 °C with 5% CO2. The cells were then washed to remove debris, and the plating medium was replaced with fresh medium, which was subsequently changed every 48 h. Experiments were conducted after signal stabilization. On the day of drug application, the culture medium was first replaced with fresh medium containing pretreatment agents (e.g., PTX, gallein, U73122, and ML277). After 4 h, the medium was again replaced with fresh medium containing both pretreatment agents and SAL. Cellular signals were recorded at 1-min intervals for the first 15 min, then at 5-min intervals for the remaining 45 min, for a total recording duration of 1 h. Extracellular field potential (EFP) signals were analyzed using CardioExcyte Control software. Arrhythmia-like events observed in EFP waveforms were defined as “cell arrhythmias,” according to previous studies14. Arrhythmias in hiPSC-CMs were classified as normal, early afterdepolarization (EAD), rolling EADs, irregular beats, tachyarrhythmias, or cell arrest according to established criteria, with severity scores ranging from 0 to 515. Solutions and chemicals SAL (Sigma, USA) and gallein (Tocris, USA) were prepared as stock solutions in dimethyl sulfoxide (DMSO) and stored in the dark. U73122 (MedChemExpress, USA) was also prepared as a stock solution in DMSO. PTX (List Biological Laboratories, USA) and D-galactose (D-gal; Sigma, USA) were prepared as stock solutions in water. All stock solutions were stored at − 20 °C. The final concentration of DMSO in the external solution did not exceed 0.1%. Other commonly used chemicals were purchased from Sigma. Statistical analysis The sample size for each experiment is specified in the figure legends or described in the corresponding Results section. All statistical analyses were conducted using GraphPad Prism 7 (GraphPad Software, Inc.) and SPSS version 20 (SPSS, Inc.). Data are presented as mean ± SEM. Comparisons were performed using paired Student’s t-tests for within-group comparisons (before and after drug treatment) and unpaired Student’s t-tests for between-group comparisons involving two independent groups. The Mann–Whitney U test and the Wilcoxon matched-pairs signed-rank test were performed to compare data with skewed distributions. Categorical data were analyzed using χ2 tests. Results with P < 0.05 were considered statistically significant. Results Age-related differences in cardiac histological characteristics and biomarkers We first examined age-dependent differences in LV myocardial structure. H&E staining and Masson’s trichrome staining revealed that the myocardial tissue did not significantly change with age. However, myocardial fibrosis increased in the old group compared with the young group (Fig. 1A). It has been established that β-galactosidase and ROS are candidate markers of cellular senescence. Consistent with this, the levels of ROS and β-galactosidase were markedly higher in aging guinea pig hearts (Figs. 1B and C). Additionally, the heart weight index showed no significant age-related changes, suggesting the absence of age-associated myocardial hypertrophy (Fig. 1D). Collectively, these findings indicate the absence of pathological structural remodeling in the aged guinea pig hearts used in this study. Age-related differences in cardiac histology and biomarkers. (A) Representative H&E staining and Masson’s trichrome staining of myocardial tissues. Scale bar = 50 μm. (B) Representative ROS fluorescence plots of myocardial tissue obtained using DCFH-DA staining. Scale bar = 100 μm. (C) Representative β-galactosidase staining of myocardial tissue. Scale bar = 50 μm. (D) Relative weight ratio of the heart. HW, heart weight; BW, body weight. n ≥ 7 guinea pigs per group. Data are presented as mean ± SEM. Age-related differences in cardiac electrophysiological characteristics Previous studies have identified three distinct cell types within the ventricular myocardium: epicardial, M, and endocardial cells. Preferential prolongation of the M-cell AP contributes to the development of transmural dispersion of repolarization, which can be estimated from the ECG as the interval between the peak and the end of the T wave (Tp–e). Increased repolarization heterogeneity has been associated with severe and potentially life-threatening arrhythmia, including torsades de pointes and other forms of VT16. In this study, in vivo ECG recordings were performed on guinea pigs, and representative waveforms are shown in Fig. 2A. Analysis of the ECG data revealed significant prolongation of the PR, RR, QTc, and Tp–e intervals in the aging guinea pigs. Additionally, the Tp–e/QTc ratio, an indicator of arrhythmia risk, was significantly increased (P < 0.05 or P < 0.01; Figs. 2B–F). APs were subsequently recorded from dissociated guinea pig LV cardiomyocytes using the conventional patch-clamp technique (Fig. 3A). Statistical analysis of APD repolarization to 90% (APD90) revealed that APD90 in cells from the young group shortened in a frequency-dependent manner (P < 0.01), whereas cells from the aging group did not exhibit this response (Fig. 3B). Comparisons between the two groups further revealed that, at all tested stimulation frequencies, APD90 values were longer in the old group than in the young group, with a statistically significant difference observed at a stimulation frequency of 2 Hz (P < 0.05; Fig. 3B). Further analysis revealed that the extent of APD90 shortening in ventricular cardiomyocytes from the old group was significantly smaller than that observed in the young group (P < 0.05 or P < 0.01; Fig. 3C). Taken together, these findings suggest delayed ventricular repolarization in aging guinea pigs. Age-related differences in surface ECG parameters. (A) Representative in vivo ECG recordings. (B–F) Summary data for the quantification of the QTc interval (B), RR interval (C), PR interval (D), Tp–e interval (E), and Tp–e/QTc ratio (F). n ≥ 6 guinea pigs per group. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01 vs. the young group. Age-related differences in action potential from isolated left ventricular myocytes. (A) Representative AP traces recorded at pacing frequencies of 0.5, 1, and 2 Hz. (B) Summary data for APD90 measured at the indicated pacing frequencies. (C) Percentage change in APD90 relative to baseline (0.5 Hz). n = 15 cells from five hearts per group. Data are expressed as mean ± SEM. **P < 0.01 vs. 0.5 Hz. #P < 0.05, ##P < 0.01 vs. the young group. Age-related differences in susceptibility to arrhythmogenesis Considering that β2AR–Gi signaling is upregulated during aging, we next evaluated age-dependent differences in susceptibility to arrhythmogenesis following acute stimulation with SAL (5 and 10 µM), a well-established selective β2AR agonist with approximately 20-fold higher affinity for β2AR than for β1AR17. Langendorff-perfused isolated hearts (ex vivo) were used, thereby precluding the effects of hormone and neurotransmitter levels. Representative in vitro ECG waveforms in the presence of SAL are shown in Fig. 4A. Analysis of the ECG data revealed that SAL typically shortened the QTc interval in a concentration-dependent manner in young animals (Fig. 4B). In young hearts, the response to β2AR stimulation was consistent with preserved physiological repolarization reserve. Conversely, in aging guinea pig hearts, the extent of QTc interval shortening was significantly smaller than that in young hearts (P < 0.05; Fig. 4B). However, a clear concentration-dependent trend was not observed. These findings suggest a reduced repolarization reserve in aging animals. PVCs occurring within 20 min after SAL perfusion were quantified. The results showed that the number of PVCs in aging animals was significantly greater than that in young animals (P < 0.05; Fig. 4C). Further analysis revealed that the incidence of severe ventricular arrhythmias (e.g., VT/VF) was 4/5 in aging hearts and 0/5 in young hearts (P < 0.05; Fig. 4D). These data indicate that acute exposure to SAL increases the propensity for ventricular tachyarrhythmias in aging guinea pig hearts compared with young hearts. Age-related differences in susceptibility to arrhythmogenesis. (A) Representative ECG waveforms from ex vivo guinea pig hearts in the presence or absence of SAL (5 and 10 µM). Representative traces of ventricular arrhythmia shown at the bottom. (B) Percentage change in QTc intervals following SAL treatment relative to baseline. (C) Quantification of PVCs within 20 min after SAL treatment. (D) Incidence of VT/VF induced by SAL. n = 5 hearts per group. Data are expressed as mean ± SEM. *P < 0.05 vs. control within the same group. #P < 0.05 vs. the young group. Involvement of β2AR-mediated signaling pathways in age-dependent ventricular arrhythmias in isolated perfused hearts To examine the role of IKs in age-dependent arrhythmogenesis, isolated hearts from aging guinea pigs were pretreated with IKs activator ML277 before exposure to SAL. As shown in Figs. 5A and B, SAL did not induce ventricular arrhythmias in aging hearts pretreated with ML277 (1 µM). In parallel, the QTc interval reflecting the duration of ventricular repolarization exhibited concentration-dependent shortening, as observed in young hearts (P < 0.05). This finding highlights the critical role of IKs in modulating arrhythmia susceptibility in aging hearts during β2AR activation. It is well established that cardiac β2AR, but not β1AR, can couple to Gi, which is sensitive to PTX18. Previous studies have shown that Gi mediates the decreased contractile response to isoproterenol (ISO) in myocytes from aging guinea pig hearts19. Additionally, our previous study showed that ISO induces an acute reduction in cardiac IKs in aging guinea pig hearts, which is mediated by β2AR–Gi8. Therefore, we hypothesized that Gi and its potential downstream effectors may be involved in the increased susceptibility to arrhythmogenesis in aging hearts. We next investigated the effect of pharmacologically pretreating aging isolated hearts before SAL exposure. The results showed that pretreatment with the Gi inhibitor PTX (1.5 µg/mL; Fig. 5C), Gβγ inhibitor gallein (100 µM; Fig. 5E), and phospholipase C (PLC) inhibitor U73122 (1 µM; Fig. 5G) prevented SAL-induced ventricular arrhythmia. QTc exhibited concentration-dependent shortening as seen in young hearts (P < 0.01 or P < 0.05; Fig. 5D, F, H). As IP3 is a direct downstream product of PLC-mediated PIP2 hydrolysis, we measured its levels in myocardial tissue obtained from isolated perfused aged hearts to assess Giβγ–PLC signaling activation. IP3 content was significantly increased following SAL treatment alone, whereas this effect was markedly attenuated by co-administration of SAL with PTX, gallein, or U73122 (P < 0.01 or P < 0.05; Fig. 6). These data support the involvement of the Giβγ–PLC signaling pathway as β2AR downstream effectors in modulating susceptibility to arrhythmia in aging hearts. Involvement of Giβγ–PLC signaling in ventricular arrhythmias in isolated perfused hearts. (A, C, E, G) Representative ECG waveforms from ex vivo aging guinea pig hearts pretreated with ML277 (1 µM, A), PTX (1.5 µg/mL, C), gallein (100 µM, E) or U73122 (1 µM, G), followed by SAL (5 and 10 µM). (B, D, F, H) Percentage change in QTc interval relative to baseline after SAL treatment in hearts pretreated with ML277 (B), PTX (D), gallein (F), or U73122 (H). n = 4 hearts per group. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01 vs. the pretreatment condition. Effects of Giβγ–PLC signaling inhibition on IP3 levels in myocardial homogenates from aged hearts. (A) Standard curve for the IP3 ELISA. Serial dilutions of IP3 standards (0–10,000 pg/mL) used to generate a four-parameter logistic (4-PL) curve R2 = 0.996. (B) IP3 content in myocardial tissue after treatment with SAL (10 µM) alone or in combination with PTX (1.5 µg/mL), gallein (100 µM), or U73122 (1 µM). (C) Fold change in IP3 levels normalized to the control condition. n = 5 hearts per group. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01 vs. the contorl condition. Involvement of β2AR-mediated signaling pathways in age-dependent cellular arrhythmias in hiPSC-CMs To further examine age-dependent arrhythmogenesis, an aging hiPSC-CM model was established using D-gal to simulate human cardiac aging. ROS and β-galactosidase levels were significantly increased after incubation with D-gal (10 g/L) for 72 h, indicating that hiPSC-CMs exhibited an aging phenotype (Fig. S1A and B). The time course of EFP alteration induced by D-gal is shown in Fig. S1C. We observed that D-gal typically reduced FP amplitude and induced shaking after 72 h of incubation, suggesting an age-dependent alteration in the electrical activity of hiPSC-CMs. To further assess cell viability in D-gal–induced senescent hiPSC-CMs, CCK-8 assays were performed. Compared with control cells, treatment with 10 g/L D-gal for 24, 48, and 72 h showed no significant effect on cell viability (Fig. S2A). Additionally, base impedance, a recognized indicator of cell viability, was continuously monitored. The results showed that the base impedance did not change significantly during the 72-h D-gal treatment (Fig. S2B). Collectively, these findings indicate that the selected concentration and duration of D-gal treatment effectively induce senescence without compromising cell viability. Based on the findings described above, we further assessed the role of β2AR-mediated signaling in arrhythmia susceptibility in hiPSC-CMs. Representative FP traces before and after the SAL challenge, in the presence or absence of D-gal, are shown in Figs. 7A1 and B1. Analysis revealed that SAL typically shortened the heart rate–corrected FP duration (FPDc), reflecting repolarization duration in hiPSC-CMs (Figs. 7A6, B6). However, in D-gal–induced aging hiPSC-CMs, the extent of FPDc shortening was significantly smaller than that in control cells (P < 0.05; Fig. 6C), indicating diminished repolarization reserve capacity in aging cells. Additionally, the incidence of SAL-induced arrhythmias was 3/3 in aging cells and 0/3 in control cells (P < 0.05; Fig. 7D). Pharmacological interventions were subsequently evaluated in the presence of SAL (Figs. 7A3–A5, B3–B5). The data revealed that PTX, gallein, and U73122 did not affect FPDc in control cells (Figs. 7A6 and C). However, in aging cells, SAL evoked significant shortening of FPDc in the presence of each of these three inhibitors (P < 0.01 or P < 0.05; Fig. 7B6 and C). Similarly, ML277 shortened FPDc in both control and aging cells. A scoring system was applied to evaluate the type and severity of cellular arrhythmias (Fig. 7E). SAL increased the incidence of arrhythmias in aging cells, whereas incubation with PTX, gallein, U73122, or ML277 reduced arrhythmia incidence and prevented the occurrence of tachyarrhythmias (P < 0.05; Fig. 7D and F). Collectively, these results indicate increased arrhythmia susceptibility in D-gal–induced aging hiPSC-CMs. Inhibition of Giβγ–PLC signaling or activation of IKs appears to confer protective effects against arrhythmias. Notably, D-gal treatment accelerated the basal electric rhythm in hiPSC-CMs, which may be relevant to age-related cardiac adaptation and compensation mechanisms. Involvement of Giβγ–PLC signaling in cell arrhythmias in hiPSC-CMs. (A1–A5) Representative extracellular field potential (EFP) waveforms recorded from control hiPSC-CMs under baseline conditions or after pretreatment with ML277 (1 µM, A2), PTX (1.5 µg/mL, A3), gallein (100 µM, A4) and U73122 (1 µM, A5), followed by salbutamol (SAL, 10 µM). (A6) Normalized FPDc from recordings shown in A1–A5. (B1–B5) Representative EFP waveforms from D-gal–induced aging hiPSC-CMs under the same experimental conditions. (B6) Normalized FPDc from recordings shown in B1–B5. (C) Percentage change in FPDc from recordings shown in A and B. (D) Incidence of tachyarrhythmias induced by SAL. (E) Representative types of cellular arrhythmia recorded in hiPSC-CMs. (F) Heatmap of arrhythmia scores under different treatment conditions. n ≥ 3 per group. Data are expressed as mean ± SEM. **P < 0.01 vs. control within the same group. #P < 0.05 for intergroup comparisons. Discussion The major finding of this study is the demonstration of an increased age-related cardiac susceptibility to arrhythmias following β2AR activation. The data further suggest that inhibition of the Giβγ–PLC signaling pathway or activation of IKs in aging hearts enhances repolarization reserve and may reduce the risk of arrhythmias. Cardiac aging is characterized by structural and functional alterations in the myocardium, which may ultimately contribute to heart failure20. In this study, guinea pigs aged 24 months or older represented an early stage of aging, as no marked structural alterations were observed apart from increased myocardial fibrosis. Nevertheless, neurohumoral dysregulation appears to be a critical pathogenic factor that substantially influences cardiac electrophysiology in the aging heart, independent of underlying structural remodeling. Aging is defined by several well-established hallmarks—genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication—each of which is directly related to the aging process21. Accordingly, several biomarkers have been identified for assessing aging status, including ROS and β-galactosidase. In this study, elevated levels of ROS and β-galactosidase were observed in both aging guinea pig hearts and hiPSC-CMs following chronic D-gal incubation, indicating that both models recapitulate key hallmarks of aging. Our findings suggest that age-related alterations in electrophysiological properties may precede structural remodeling in the myocardium. Prolongation of the QT interval has been reported in both human and animal models during aging22,23, suggesting either an increase in inward currents (e.g., L-type Ca2+ current) and/or a reduction in outward K+ currents. The IKs is a major repolarizing current during phases 2 and 3 of the ventricular AP in large mammals. Sympathetic nervous system excitation during exercise or stress substantially enhances IKs, concomitant with a rise in the heart rate, leading to the shortening of the APD at the cellular level and a reduced QT interval on the ECG2. This response directly reflects the functional capacity of the cardiac repolarization reserve. In aging guinea pigs, both in vivo and in vitro experiments indicated prolonged QTc and APD at baseline compared with young controls, along with blunted shortening of QTc and APD in response to SAL stimulation or rapid pacing. These consistent findings across independent experimental approaches substantiate the notion that aging impairs cardiac repolarization reserve, manifesting as delayed repolarization. Previous studies have also shown that the aged heart exhibits substantially reduced QTc interval shortening in response to acute isoproterenol stimulation compared with the young heart8, which is consistent with the present observations. βAR activation by sympathetic excitation serves as a major trigger for sudden cardiac death in the aging population. In mammalian hearts, including those of humans, native β2ARs are coupled to both Gs and PTX-sensitive Gi signaling pathways, whereas β1ARs exclusively activate the Gs cascade. Accumulating evidence indicates that the aging heart is characterized by an increased β2AR-to-β1AR ratio and a shift in β2AR signaling coupling from Gs toward Gi, resulting in upregulation of the β2AR–Gi pathway. In this study, the selective β2AR agonist SAL-induced substantial QTc interval shortening in young guinea pig hearts. This response was absent in aging hearts, which exhibited blunted QTc shortening, suggesting an impaired repolarization reserve. Consequently, aging hearts were markedly more susceptible to ventricular tachyarrhythmias in vitro. Previous studies have also confirmed that β2AR stimulation can be arrhythmogenic in heart failure, mediated by sarcoplasmic reticulum Ca overload, which promotes spontaneous Ca release and aftercontractions24. Notably, the SAL concentrations used in this study (5 and 10 µM) selectively activate β2AR, as supported by evidence indicating that even higher SAL concentrations (50 µM) do not markedly engage β1AR in the absence of the selective β2AR antagonist ICI11855125. From a mechanistic perspective, β-adrenergic enhancement of IKs exerts antiarrhythmic effects by counteracting the concomitant increase in the inward current. However, our previous study reported a pronounced decrease in IKs following ISO treatment in aging guinea pig ventricular myocytes8. These previous findings emphasize a critical link between age-dependent arrhythmia and βAR activation, particularly under conditions of biased β2AR–Gi coupling. Although the SAL concentrations used in this study exceed typical clinical levels, they are consistent with those commonly used in isolated heart and cardiomyocyte studies to examine β2AR signaling mechanisms. These concentrations may also reflect elevated local catecholamine levels during intense sympathetic activation, such as in heart failure or acute stress. Nevertheless, extrapolation of these findings to in vivo conditions should be approached with caution. G proteins exist as heterotrimers composed of Gα, Gβ, and Gγ subunits. Upon activation, the heterotrimer dissociates into a Gα subunit and a Gβγ dimer, with the Gβγ dimer anchored to the plasma membrane through lipid modifications on the Gγ subunit26. Although early studies primarily focused on Gα-mediated signaling, recent studies have indicated that Gβγ contributes more substantially to G protein–mediated signaling, largely due to the diversity of Gβ and Gγ subtypes. The Gβγ typically acts as a scaffold, recruiting cytosolic effectors to the plasma membrane to facilitate their interaction with target substrates, such as ion channels. PLC is a critical downstream effector of Gβγ signaling. Previous studies have shown that PTX-sensitive Gβγ activates PLC27. Furthermore, β2AR activation has been shown to protect against cardiac hypertrophy by inhibiting Golgi-localized PLCε signaling through Gi and Gβγ28. Thus, we evaluated the potential involvement of these putative downstream effectors in β2AR-induced arrhythmia using pharmacological inhibitors, including the Gi inhibitor PTX, the Gβγ inhibitor gallein, and the PLC inhibitor U73122. None of these inhibitors markedly affected baseline QTc intervals; however, they all counteracted arrhythmogenesis in aging hearts by restoring concentration-dependent QTc shortening in response to SAL. These findings support the involvement of a Giβγ–PLC-mediated mechanism. Additionally, pretreatment of aging hearts with ML277, an IKs channel opener, resulted in marked shortening of the QTc interval both at baseline and after the SAL challenge, indicating the presence of a functionally responsive pool of IKs channels in the aging heart. Collectively, these findings suggest that β2AR–Giβγ–PLC signaling may promote arrhythmogenesis in aging guinea pig hearts by suppressing IKs current. PLC catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2), a plasma membrane phospholipid that stabilizes the open state of IKs channels29. Thus, age-associated alterations in cardiac PIP2 levels may represent an important area for future investigation. These findings also emphasize the important role of IKs in adrenergic-induced repolarization acceleration and may explain why heart failure or aging hearts exhibit an excessive prolongation of QT intervals during elevated sympathetic activity. However, the role of β2AR signaling in ventricular arrhythmias remains unclear. While previous studies in canines have shown that enhanced sensitivity to β2-adrenergic stimulation predisposes to ventricular arrhythmias and sudden death30, other evidence suggests that β2AR activation may exert protective effects against cardiac hypertrophy and heart failure in mice28. This discrepancy may reflect species-specific differences and their distinct pathophysiological conditions. HiPSC-CMs are widely used as a preclinical model for cardiotoxicity testing and provide a critical experimental platform for validating model-based predictions of drug effects within the Comprehensive in vitro Proarrhythmia Assay initiative. Although reports commonly describe hiPSC-CMs as exhibiting heterogeneous functional readouts and an immature phenotype, they retain key electrophysiological properties comparable to those of the adult human heart31. Previous studies have shown that hiPSC-CMs express both β1ARs and β2ARs, and that they progressively develop T-tubules and caveolae32,33. The D-gal–induced aging model can mimic the senescence-associated characteristics of natural aging and has gained increasing application in cardiovascular research34. In this study, D-gal was used to induce senescence in hiPSC-CMs, and the model reproduced a shared phenotype of increased susceptibility to β2AR-stimulated arrhythmias, consistent with observations in aged guinea pig hearts. Pharmacological interventions with ML277, PTX, gallein, and U73122 each produced antiarrhythmic effects in hiPSC-CMs by accelerating repolarization during the SAL challenge. A previous study examining the age-dependent maturation of hiPSC-CMs reported that β2AR expression progressively increased, reaching up to a fivefold elevation over 90 days of continuous culture, and remained consistently higher than β1AR levels35. This finding provides a causative explanation for the present observations. Notably, an unexpected finding was that D-gal–induced senescence accelerated the basal beating rate in hiPSC-CMs. This effect may reflect a compensatory response to either mitochondrial dysfunction or inflammatory activation induced by aging. Several limitations of this study should be acknowledged. First, AP recordings would have been more physiologically representative if patch-clamp experiments had been conducted at physiological temperatures. Second, although the protective effects observed with ML277 provide pharmacological evidence for the involvement of IKs, direct measurement of IKs current would provide more definitive evidence to clarify its relationship with Giβγ–PLC signaling. Conclusion The findings of this study indicate that β2AR activation induces increased susceptibility to arrhythmogenesis in aging hearts. Inhibition of the Giβγ–PLC signaling cascade or activation of the IKs channel accelerates repolarization and provides protection against arrhythmias. Recent epidemiological evidence has identified advanced age as an independent risk factor for arrhythmia-related mortality36,37. Increased sympathetic activity and reduced β-adrenergic responsiveness are among the most prominent age-related cardiovascular alterations, constituting key pathophysiological factors that underlie tachydysrhythmias. Collectively, these findings provide novel insights into the molecular basis of enhanced cardiac arrhythmia susceptibility and may inform improvements in preventive and therapeutic strategies for older patients. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements We appreciate the support of Professor Xu Yanfang and the Department of Pharmacology, Hebei Medical University, for their contributions to this study. Author contributions C.L. and S.Z. conceptualized and designed the project. S.Z., Y.W., J.C., L.Y., L.G. and K.L. performed the experiments and interpreted the results. S.Z., X.W. and C.L. analyzed the data. S.Z. wrote the manuscript. C.L. edited the manuscript. C.L. supervised the project. All authors have read and agreed to the published version of the manuscript. Funding This study was supported by the Natural Science Foundation of Hebei Province (H2023206320); the Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine (2025337); and the Scientific Research Project of Hebei Medical University Third Hospital (ydsypy202406; ydsyzyy202401). Data availability All data used for the analyses in this report are available from the corresponding author on reasonable request. Declarations Competing interests The authors declare no competing interests. Institutional review board All experiments were conducted following the recommendations outlined in the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. The experimental protocol was reviewed and approved by the Animal Care and Use Committee of Hebei Medical University (approval number: 1604087, Shijiazhuang, China). Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement All data used for the analyses in this report are available from the corresponding author on reasonable request.